Skip to main content
. 2022 Jul 19;24:101480. doi: 10.1016/j.tranon.2022.101480

Table 2.

Demographic and clinical characteristics of patients with GCLM in CSS group.

Characteristics All samples
N Percentage
(%)
Training
N Percentage
(%)
Validation
N Percentage
(%)
P
Age(years)
  <65 773 44.20% 523 44.06% 250 44.48% 0.8678
  >65 976 55.80% 664 55.94% 312 55.52%
Sex
  female 476 27.22% 337 28.39% 139 24.73% 0.1085
  male 1273 72.78% 850 71.61% 423 75.27%
Race
American Indian/Alaska Native 16 0.91% 10 0.84% 6 1.07% 0.9427
 Asian/Pacific Islander 194 11.09% 134 11.29% 60 10.68%
  Black 281 16.07% 189 15.92% 92 16.37%
  White 1258 71.93% 854 71.95% 404 71.89%
Primary Site
  Cardia 741 42.37% 507 42.71% 234 41.64% 0.9731
  Pylorus 88 5.03% 58 4.89% 30 5.34%
  Body 153 8.75% 107 9.01% 46 8.19%
  Antrum 265 15.15% 182 15.33% 83 14.77%
  Fundus 26 1.49% 17 1.43% 9 1.60%
 Lesser curve 104 5.95% 70 5.90% 34 6.05%
 Greater curve 60 3.43% 42 3.54% 18 3.20%
 Other 312 17.84% 204 17.19% 108 19.22%
Histologic type
Adenocarcinoma 1452 83.02% 983 82.81% 469 83.45% 0.9448
Signet ring cell 127 7.26% 87 7.33% 40 7.12%
Special type 170 9.72% 117 9.86% 53 9.43%
Grade
  I 43 2.46% 31 2.61% 12 2.14% 0.0936
  II 553 31.62% 374 31.51% 179 31.85%
  III 1113 63.64% 762 64.20% 351 62.46%
  IV 40 2.29% 20 1.68% 20 3.56%
T Stage
  T0 2 0.11% 1 0.08% 1 0.18% 0.9488
  T1 688 39.34% 472 39.76% 216 38.43%
  T2 99 5.66% 65 5.48% 34 6.05%
  T3 418 23.90% 283 23.84% 135 24.02%
  T4 542 30.99% 366 30.83% 176 31.32%
N Stage
  N0 674 38.54% 459 38.67% 215 38.26% 0.9483
  N1 788 45.05% 537 45.24% 251 44.66%
  N2 144 8.23% 97 8.17% 47 8.36%
  N3 143 8.18% 94 7.92% 49 8.72%
Radiotherapy
  Yes 325 18.58% 215 18.11% 110 19.57% 0.4635
  No 1424 81.42% 972 81.89% 452 80.43%
Chemotherapy
  Yes 1061 60.66% 727 61.25% 334 59.43% 0.4678
  No 688 39.34% 460 38.75% 228 40.57%
Surgery
 Yes 240 13.72% 161 13.56% 79 14.06% 0.7795
 No 1509 86.28% 1026 86.44% 483 85.94%
Bone Metastasis
 Yes 157 8.98% 103 8.68% 54 9.61% 0.5246
 No 1592 91.02% 1084 91.32% 508 90.39%
Brain Metastasis
 Yes 24 1.37% 13 1.10% 11 1.96% 0.1478
 No 1725 98.63% 1174 98.90% 551 98.04%
Lung Metastasis
 Yes 297 16.98% 199 16.76% 98 17.44% 0.7264
 No 1452 83.02% 988 83.24% 464 82.56%
Marital Status
 Yes 1086 62.09% 746 62.85% 340 60.50% 0.3443
 No 663 37.91% 441 37.15% 222 39.50%